首页|卡格列净与阿米洛利或苯扎米尔联用对肾病综合征大鼠骨代谢的影响

卡格列净与阿米洛利或苯扎米尔联用对肾病综合征大鼠骨代谢的影响

扫码查看
目的 探讨钠-葡萄糖协同转运蛋白2抑制剂(SGLT2i)卡格列净和上皮钠通道阻滞剂阿米洛利或苯扎米尔联用对阿霉素诱导的肾病综合征(NS)模型大鼠骨代谢的影响.方法 取49只雄性SD大鼠,随机抽取7只为对照组(NG组).其余42只通过尾静脉注射阿霉素造模并随机分为模型组(MG组)、卡格列净组(KG组)、苯扎米尔组(BH组)、阿米洛利组(AL组)、卡格列净+苯扎米尔组(KB组)、卡格列净+阿米洛利组(KA组),每组7只.各用药组每日定时按大鼠体质量予以灌胃,NG组和MG组给予等量生理盐水,疗程6周.治疗前1 d检测各组大鼠的24 h尿蛋白(24 h-UTP),验证模型制备成功.治疗后第6周,分别检测各组大鼠的24 h-UTP、尿钠(UNa)、尿钾(UK)以及血清白蛋白(ALB)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白(LDL)、血钙(SCa)、血钠(SNa)、血钾(SK)、25-羟维生素D(25-OH-D)、碱性磷酸酶(ALP)、甲状旁腺素(PTH)、Ⅰ型前胶原氨基端原肽(PINP)和Ⅰ型胶原羧基端肽β特殊序列(β-CTX)水平.结果 造模成功后,MG组的24 h-UTP、TG、TC、LDL、SCa水平均升高,ALB、25-OH-D、ALP、PINP、PTH水平均降低,差异有统计学意义(P<0.05或P<0.01).药物干预6周后,KG组大鼠体质量下降,差异有统计学意义(P<0.05).与MG组比较,各药物组的24 h-UTP、TC、TG、LDL、SCa水平降低,ALB水平升高,差异有统计学意义(P<0.05或P<0.01).与MG组比较,KA组的25-OH-D、ALP、PINP、β-CTX水平升高,差异有统计学意义(P<0.05或P<0.01).造模及药物治疗对UNa、UK、SK、SNa水平无影响(P>0.05).结论 单用卡格列净、苯扎米尔组、阿米洛利以及卡格列净分别联合苯扎米尔、阿米洛利用药均可改善阿霉素诱导的NS模型大鼠的大量蛋白尿、低蛋白血症和高脂血症.联用卡格列净和阿米洛利具有显著的促成骨作用或促破骨作用,其可能通过形成新的成骨/破骨平衡,进而发挥降低NS大鼠骨折风险的作用.
Effects of canagliflozin combined with amiloride or benzamil on bone metabolism in rats with nephrotic syndrome
Objective To investigate the effects of sodium-glucose cotransporter 2 inhibitor(SGLT2i)canagliflozin and epithelial sodium channel inhibitor amiloride or benzamil in combination on the bone metabolism in the rats with the nephrotic syndrome(NS)induced by doxorubicin.Methods In the 49 male SD rats selected,7 were randomly selected as control group(NG),and 42 were built as adria-mycin-induced nephropathy model by injecting adriamycin through the tail vein,and were randomly di-vided into model group(MG group),canagliflozin group(KG group),benzamil group(BH group),amiloride group(AL group),canagliflozin+benzamil group(KB group)and canagliflozin+amiloride group(KA group),with 7 cases in each group.Each medication group was given intragastric administration according to the body weight of rats regularly every day,NG group and MG group were given equal amount of normal saline,the course of treatment was 6 weeks.The 24-hour urinary protein(24 h-UTP)of each group was detected one day before treatment to verify the successful preparation of the model.At 6 weeks after treatment,the 24 h-UTP,urine sodium(UNa),urinary potassium(UK)levels in urine and the albumin(ALB),triglyceride(TG),cholesterol(TC),low density lipoprotein(LDL),serum calcium(SCa),sodium(SNa),potassium(SK),25-hydroxyvitamin D(25-OH-D),alkaline phosphatase(ALP),parathyroid hormone(PTH),procollagen type ⅠN-terminal propeptide(PINP)and beta C-terminal cross-linked telopeptides of type Ⅰ collagen(β-CTX)levels in serum were measured,respectively.Results After successful modeling,the levels of 24 h-UTP,TG,TC,LDL and SCa in the MG group were significantly increased,while the levels of ALB,25-OH-D,ALP,PINP and PTH were significantly decreased(P<0.05 or P<0.01).After 6 weeks of drug intervention,the body mass of rats treated with KG alone decreased significantly(P<0.05).Compared with the MG group,the levels of 24 h-UTP,TC,TG,LDL and SCa were significantly decreased,and the level of ALB was significantly increased in all drug groups when compared to the MG(P<0.05 or P<0.01).Compared with the MG group,the levels of 25-OH-D,ALP,PINP and β-CTX in the KA group were significantly increased when compared to the MG(P<0.05 orP<0.01).Molding and drug therapy had no impact on levels of UNa,UK,SK and SNa(P>0.05).Conclusion Calaglizin alone,benzamil alone,amiloride alone and cala-glizin combined with benzamil or amiloride can improve the mass proteinuria,hypoproteinemia and hyperlipidemia in adriamycin-induced NS model rats.The combination of caraglipzin and amiloride has a significant osteogenic or osteoclastic effect,which may play a role in reducing the risk of frac-ture in NS rats by forming a new osteogenic/osteoclastic balance.

nephrotic syndromesodium-glucose cotransporter 2 inhibitorepithelial sodium channel blockerscanagliflozinamiloridebenzamilbone metabolism

环薇、李潇、洪文娟、罗晓菲、王学芳、李倩、成家茂

展开 >

大理大学临床医学院,云南大理,671003

大理大学第一附属医院肾脏内科,云南大理,671013

大理大学基础医学院解剖教研室,云南大理,671003

肾病综合征 钠-葡萄糖协同转运蛋白2抑制剂 上皮钠通道阻滞剂 卡格列净 阿米洛利 苯扎米尔 骨代谢

2023年度云南省教育厅科学研究基金研究生项目云南省大理市2022年科技计划项目2022年度大理大学第一附属医院杰出中青年人才项目

2023Y09732022KBG059DFYJC-202108

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(2)
  • 26